SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full-Year 2023 on March 5, 2024
2024年2月21日 - 12:46AM
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and
a leader in data-driven medicine, today announced it will release
its financial results for the fourth quarter and full-year 2023
before U.S. markets open on Tuesday, March 5, 2024. On that day,
SOPHiA GENETICS will host a conference call to discuss its
financial results as well as business outlook beginning at 8:00
a.m. (08:00) EDT / 2:00 p.m. (14:00) CET.
The call will be webcast live on the SOPHiA GENETICS
Investor Relations website. Additionally, a replay will be
available on the website after its completion.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a software company dedicated
to establishing the practice of data-driven medicine as the
standard of care and for life sciences research. It is the creator
of the SOPHiA DDM™ Platform, a cloud-native platform capable of
analyzing data and generating insights from complex multimodal data
sets and different diagnostic modalities. The SOPHiA DDM™ Platform
and related solutions, products, and services are currently used by
a broad network of hospital, laboratory, and biopharma institutions
globally. For more information, visit SOPHiAGENETICS.COM, or
connect on X, LinkedIn, Facebook,
and Instagram. Where others see
data, we see answers.
Investor Contact
Kellen Sanger
IR@sophiagenetics.com
Media Contact
Kelly Katapodis
media@sophiagenetics.com
Sophia Genetics (NASDAQ:SOPH)
過去 株価チャート
から 10 2024 まで 11 2024
Sophia Genetics (NASDAQ:SOPH)
過去 株価チャート
から 11 2023 まで 11 2024